CorVel vs Sotera Health
Sotera Health reported revenue of $1.2 billion in fiscal 2025, 1.2 times CorVel's $958 million in fiscal 2026. CorVel's revenue grew 7.0% in its latest year, and Sotera Health's grew 5.7%. Free cash flow was $110 million at CorVel and $149 million at Sotera Health. Their fiscal years end in different months (March 31 and December 31), so the periods don't line up exactly.
Side by side
| CorVel | Sotera Health | |
|---|---|---|
| Latest fiscal year | FY2026, Mar 31, 2026 | FY2025, Dec 31, 2025 |
| Revenue | $958M | $1.2B |
| Revenue growth | 7.0% | 5.7% |
| Revenue growth a year, last 5 years | 11.6% | 7.3% |
| Gross margin | 24.3% | 55.5% |
| Operating margin | — | — |
| Net margin | 11.5% | 6.7% |
| Free cash flow | $110M | $149M |
| Free cash flow margin | 11.5% | 12.8% |
| Return on capital | — | 6.7% |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $56M | $0M |
| Change in diluted share count | −0.7% | 0.5% |
| Last close | $84.59 | $18.39 |
| P/E at the last close | 37.6× | 32.3× |
| Insider trades, last 12 months | sold $21.2 million | sold $1.6 billion |
| Piotroski F-score | — | 7 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
CorVelSotera Health
Operating margin
Percent of revenue
CorVelSotera Health
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CorVelSotera Health
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the CorVel and Sotera Health pages.